Session R.A. II - Insider Non-Derivative Transactions at Taysha Gene Therapies, Inc. (TSHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 13, 2023, Session R.A. II's relationship to Taysha Gene Therapies, Inc. (TSHA) is TenPercentOwner, and currently has 8,871,747 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TSHA insiders.
Data Source: SEC.
Session R.A. II - Insider Non-Derivative Transactions of TSHA Common Stock
Session R.A. II - Insider Non-Derivative Transactions at TSHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 14, 2023 | Sell -- (Common Stock) | 5344 | 0.7 | 8871747 |
| Jul 13, 2023 | Sell -- (Common Stock) | 80528 | 0.71 | 8877091 |
| Jun 24, 2023 | Sell -- (Common Stock) | 18100 | 0.7 | 8957619 |
| Jun 23, 2023 | Sell -- (Common Stock) | 10508 | 0.7 | 8975719 |
| Jun 22, 2023 | Sell -- (Common Stock) | 138962 | 0.7 | 8986227 |
| Jun 21, 2023 | Sell -- (Common Stock) | 295653 | 0.71 | 9125189 |
| Mar 7, 2023 | J -- (Common Stock) | 251296 | 0 | 9420842 |